LOXYGENE
ActiveSummary
LOXYGENE has been active since 2023 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €26,519 and a net result of €141. Equity is growing by about 50% per year across the filed financial years. Its solvency ranks better than 52% of 2,593 sector peers (NACE 85, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
14-07
NBB filing
Annual accounts filed
financial year 2025 · micro format
2025
04-08
NBB filing
Annual accounts filed
financial year 2024 · micro format · 4 days late
2024
07-11
NBB filing
Annual accounts filed
financial year 2023 · micro format · 99 days late
2023
04-12
Gazette deed
IncorporationAppointment: LOX Karlien Hilda Johanna (director) · Founder · Founding capital9 facts ▸
Gazette deed
Incorporation
Appointment: LOX Karlien Hilda Johanna (director) · Founder · Founding capital9 facts ▸
- Founder, LOX Karlien Hilda Johanna
- Incorporation, “LOXYGENE” (deed in Dutch)
- Other provision, 15-11-2023
- Founding capital, €100
- Other provision, “beschikbaarheid,plaatsing en storting aandelen” (deed in Dutch)
- Registered office clause, “9850 Deinze (Nevele),Gasthuisstraat 20/B, elke communicatie via dit adres aan en/of door vennootschap,bestuurders en aandeelhouders geacht geldig tot nieuw adre…” (deed in Dutch)
- Pre-incorporation commitments, “takeover, alle verbintenissen en verplichtingen die eruit voortvloeien en alle activiteiten in naam en voor rekening van vennootschap in oprichting” (deed in Dutch)
- Director appointment, LOX Karlien Hilda Johanna (director)
- Other provision, “beroepsverbod, geen beroepsverbod uitgesproken” (deed in Dutch)
Gazette deedNBB filing
1 of 1 deed read